Atlas Trials

Metastatic Clear Cell Renal Cell Carcinoma

36 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Clear Cell Renal Cell Carcinoma

RecordFirmDate
Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer (NCT04904302)M.D. Anderson Cancer Center2022-05-03
Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer (NCT05012371)M.D. Anderson Cancer Center2022-02-16
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma (NCT06428708)Western University2022-01-24
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546)City of Hope Medical Center2021-11-01
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial (NCT04510597)SWOG Cancer Research Network2021-03-08
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery (NCT04370509)University of California, San Francisco2021-02-09
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers (NCT04388852)M.D. Anderson Cancer Center2020-08-20
A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) (NCT03679767)Incyte Corporation2019-01-09
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT03334409)Academic and Community Cancer Research United2018-02-16
Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (NCT02781506)University of Texas Southwestern Medical Center2016-06-20
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma (NCT02848768)Rennes University Hospital2014-12-01
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer (NCT01896271)University of Texas Southwestern Medical Center2013-10-02
A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma (NCT01391130)Eli Lilly and Company2011-08-01
Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer (NCT02002312)Radboud University Medical Center2011-08-01

Track Metastatic Clear Cell Renal Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.